Cargando…
Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma
Preclinical and early clinical studies have demonstrated that chimeric antigen receptor (CAR)-redirected T cells are highly promising in cancer therapy. We observed that targeting HER2 in a glioblastoma (GBM) cell line results in the emergence of HER2-null tumor cells that maintain the expression of...
Autores principales: | Hegde, Meenakshi, Corder, Amanda, Chow, Kevin KH, Mukherjee, Malini, Ashoori, Aidin, Kew, Yvonne, Zhang, Yi Jonathan, Baskin, David S, Merchant, Fatima A, Brawley, Vita S, Byrd, Tiara T, Krebs, Simone, Wu, Meng Fen, Liu, Hao, Heslop, Helen E, Gottachalk, Stephen, Yvon, Eric, Ahmed, Nabil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831041/ https://www.ncbi.nlm.nih.gov/pubmed/23939024 http://dx.doi.org/10.1038/mt.2013.185 |
Ejemplares similares
-
A bispecific chimeric antigen receptor molecule enhances T cell activation through dual immunological synapse formation and offsets antigen escape in glioblastoma
por: Hegde, Meenakshi, et al.
Publicado: (2015) -
TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
por: Grada, Zakaria, et al.
Publicado: (2013) -
Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial.
por: Ahmed, Nabil, et al.
Publicado: (2015) -
Polystyrene microspheres enable 10‐color compensation for immunophenotyping of primary human leukocytes
por: Byrd, Tiara, et al.
Publicado: (2015) -
TEM8 specific T cells target the tumor cells and tumor-associated vasculature in triple negative breast cancer
por: Byrd, Tiara, et al.
Publicado: (2014)